Geisinger’s Autism & Developmental Medicine Institute (ADMI) is pleased to offer a comprehensive package of developmental services for people with 22q11.2 deletions. ADMI’s multidisciplinary team has extensive knowledge and expertise with 22q11.2 deletion syndrome, which was formerly known as DiGeorge or velocardiofacial syndrome. ADMI’s leadership in the fields of neurodevelopmental pediatrics, genomic medicine, psychology, speech-language pathology, special education, and behavioral health allows us to offer unique and practical services for children and families.
ADMI was created out of the need for a partnership between clinical and research efforts to improve outcomes for children with special developmental needs. Our vision is to expand and seamlessly integrate clinical services, innovation and research, education, and family support through a multidisciplinary team of providers and researchers.
At Geisinger's 22q Developmental Clinic in Lewisburg, Pennsylvania, families can access a variety of medical, behavioral, genetic counseling, and assessment services. In addition, ADMI’s team of specialists is available to provide local and long distance consultations to help schools, agencies, and families address the complex needs of children and adults with 22q11.2 deletions and duplications.
To learn more about our full range of services for people affected by 22q11.2 deletions and duplications, contact Emily Palen, MS, LGC, at email@example.com or 570-214-0167.
Fast facts about 22q11.2 deletion syndrome:
- The syndrome is caused by a missing section (deletion) of genetic material on chromosome 22q11.2.
- One in every 2,000 - 4,000 babies is born with 22q11.2 deletion syndrome.
- The diagnosis is confirmed through genetic testing.
- Children and adults with the deletion may show a spectrum of medical, behavioral, and learning challenges, including:
Reduced immunity to infection
Behavioral differences, such as attention deficits and autism spectrum disorder
Hearing and vision problems